A:	SECTION A HUMAN NECESSITIES
A61:	MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K:	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K6/00:	Preparations for dentistry
A61K6/02:	. Use of preparations for artificial teeth, for filling or for capping teeth
A61K6/027:	. . Use of non-metallic elements or compounds thereof, e.g. carbon
A61K6/033:	. . . Phosphorus compounds, e.g. apatite
A61K6/04:	. . Use of metals or alloys
A61K6/05:	. . . Amalgams
A61K6/06:	. . Use of inorganic cements
A61K6/08:	. . Use of natural or synthetic resins
A61K6/083:	. . . Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
A61K6/087:	. . . Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
A61K6/09:	. . . . Polyurethanes
A61K6/093:	. . . . Polyorganosilicon compounds
A61K6/097:	. . . Polysaccharides
A61K6/10:	. Compositions for taking dental impressions
A61K8/00:	Cosmetics or similar toilet preparations
A61K8/02:	. characterised by special physical form
A61K8/03:	. . Liquid compositions with two or more distinct layers
A61K8/04:	. . Dispersions; Emulsions
A61K8/06:	. . . Emulsions
A61K8/11:	. . Encapsulated compositions
A61K8/14:	. . Liposomes
A61K8/18:	. characterised by the composition
A61K8/19:	. . containing inorganic ingredients
A61K8/20:	. . . Halogens; Compounds thereof
A61K8/21:	. . . . Fluorides; Derivatives thereof
A61K8/22:	. . . Peroxides; Oxygen; Ozone
A61K8/23:	. . . Sulfur; Selenium; Tellurium; Compounds thereof
A61K8/24:	. . . Phosphorus; Compounds thereof
A61K8/25:	. . . Silicon; Compounds thereof
A61K8/26:	. . . Aluminium; Compounds thereof
A61K8/27:	. . . Zinc; Compounds thereof
A61K8/28:	. . . Zirconium; Compounds thereof
A61K8/29:	. . . Titanium; Compounds thereof
A61K8/30:	. . containing organic compounds
A61K8/31:	. . . Hydrocarbons
A61K8/33:	. . . containing oxygen
A61K8/34:	. . . . Alcohols
A61K8/35:	. . . . Ketones, e.g. quinones, benzophenone
A61K8/36:	. . . . Carboxylic acids; Salts or anhydrides thereof
A61K8/362:	. . . . . Polycarboxylic acids
A61K8/365:	. . . . . Hydroxycarboxylic acids; Ketocarboxylic acids
A61K8/368:	. . . . . with carboxyl groups directly bound to carbon atoms of aromatic rings
A61K8/37:	. . . . Esters of carboxylic acids
A61K8/38:	. . . . Percompounds, e.g. peracids
A61K8/39:	. . . . Derivatives containing from 2 to 10 oxyalkylene groups
A61K8/40:	. . . containing nitrogen
A61K8/41:	. . . . Amines
A61K8/42:	. . . . Amides
A61K8/43:	. . . . Guanidines
A61K8/44:	. . . . Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts, esters or N-acylated derivatives thereof
A61K8/45:	. . . . Derivatives containing from 2 to 10 oxyalkylene groups
A61K8/46:	. . . containing sulfur
A61K8/49:	. . . containing heterocyclic compounds
A61K8/55:	. . . containing phosphorus
A61K8/58:	. . . containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
A61K8/60:	. . . Sugars; Derivatives thereof
A61K8/63:	. . . Steroids; Derivatives thereof
A61K8/64:	. . . Proteins; Peptides; Derivatives or degradation products thereof
A61K8/65:	. . . . Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
A61K8/66:	. . . . Enzymes
A61K8/67:	. . . Vitamins
A61K8/68:	. . . Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
A61K8/69:	. . . containing fluorine
A61K8/70:	. . . . containing perfluoro groups, e.g. perfluoroethers
A61K8/72:	. . containing organic macromolecular compounds
A61K8/73:	. . . Polysaccharides
A61K8/81:	. . . obtained by reactions involving only carbon-to-carbon unsaturated bonds
A61K8/84:	. . . obtained by reactions other than those involving only carbon-to-carbon unsaturated bonds
A61K8/85:	. . . . Polyesters
A61K8/86:	. . . . Polyethers
A61K8/87:	. . . . Polyurethanes
A61K8/88:	. . . . Polyamides
A61K8/89:	. . . . Polysiloxanes
A61K8/891:	. . . . . saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
A61K8/892:	. . . . . . modified by a hydroxy group, e.g. dimethiconol
A61K8/893:	. . . . . . modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone
A61K8/894:	. . . . . . modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
A61K8/895:	. . . . . containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
A61K8/896:	. . . . . containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
A61K8/897:	. . . . . . containing halogen, e.g. fluorosilicones
A61K8/898:	. . . . . . containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
A61K8/899:	. . . . . . containing sulfur, e.g. sodium PG-propyldimethicone thiosulfate copolyol
A61K8/90:	. . . Block copolymers
A61K8/91:	. . . Graft copolymers
A61K8/92:	. . Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products
A61K8/96:	. . containing materials, or derivatives thereof, of undetermined constitution
A61K8/97:	. . . from algae, fungi, lichens or plants; from derivatives thereof
A61K8/9706:	. . . . Algae
A61K8/9711:	. . . . . Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
A61K8/9717:	. . . . . Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
A61K8/9722:	. . . . . Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
A61K8/9728:	. . . . Fungi, e.g. yeasts
A61K8/9733:	. . . . Lichens
A61K8/9739:	. . . . Bryophyta [mosses]
A61K8/9741:	. . . . Pteridophyta [ferns]
A61K8/9749:	. . . . . Filicopsida or Pteridopsida
A61K8/9755:	. . . . Gymnosperms [Coniferophyta]
A61K8/9761:	. . . . . Cupressaceae [Cypress family], e.g. juniper or cypress
A61K8/9767:	. . . . . Pinaceae [Pine family], e.g. pine or cedar
A61K8/9771:	. . . . Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
A61K8/9778:	. . . . Gnetophyta, e.g. Ephedraceae [Mormon-tea family]
A61K8/9783:	. . . . Angiosperms [Magnoliophyta]
A61K8/9789:	. . . . . Magnoliopsida [dicotyledons]
A61K8/9794:	. . . . . Liliopsida [monocotyledons]
A61K8/98:	. . . of animal origin
A61K8/99:	. . . from microorganisms other than algae or fungi, e.g. protozoa or bacteria
A61K9/00:	Medicinal preparations characterised by special physical form
A61K9/02:	. Suppositories; Bougies; Bases for suppositories or bougies
A61K9/06:	. Ointments; Bases therefor
A61K9/08:	. Solutions
A61K9/10:	. Dispersions; Emulsions
A61K9/107:	. . Emulsions
A61K9/113:	. . . Multiple emulsions, e.g. oil-in-water-in-oil
A61K9/12:	. . Aerosols; Foams
A61K9/127:	. . Liposomes
A61K9/133:	. . . Unilamellar vesicles
A61K9/14:	. Particulate form, e.g. powders
A61K9/16:	. . Agglomerates; Granulates; Microbeadlets
A61K9/18:	. . Adsorbates
A61K9/19:	. . lyophilised
A61K9/20:	. Pills, lozenges or tablets
A61K9/22:	. . Sustained or differential release type
A61K9/24:	. . . Layered or laminated unitary dosage forms
A61K9/26:	. . . Discrete particles in supporting matrix
A61K9/28:	. . Dragees; Coated pills or tablets
A61K9/30:	. . . Organic coatings
A61K9/32:	. . . . containing solid synthetic polymers
A61K9/34:	. . . . containing natural gums or resins
A61K9/36:	. . . . containing carbohydrates or derivatives thereof
A61K9/38:	. . . . containing proteins or derivatives thereof
A61K9/40:	. . . . . Gelatin containing
A61K9/42:	. . . . containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof, e.g. chocolate
A61K9/44:	. . printed, embossed, grooved, or perforated
A61K9/46:	. . effervescent
A61K9/48:	. Preparations in capsules, e.g. of gelatin, of chocolate
A61K9/50:	. . Microcapsules
A61K9/51:	. . . Nanocapsules
A61K9/52:	. . Sustained or differential release type
A61K9/54:	. . . containing discrete particles with coatings of different thicknesses or different materials
A61K9/56:	. . . . Organic coatings
A61K9/58:	. . . . . containing solid synthetic polymers
A61K9/60:	. . . . . containing natural gums or resins
A61K9/62:	. . . . . containing carbohydrates or derivatives thereof
A61K9/64:	. . . . . containing proteins or derivatives thereof
A61K9/66:	. . . containing emulsions, dispersions or solutions
A61K9/68:	. chewing gum type
A61K9/70:	. Web, sheet or filament bases
A61K9/72:	. for smoking or inhaling
A61K31/00:	Medicinal preparations containing organic active ingredients
A61K31/01:	. Hydrocarbons
A61K31/015:	. . carbocyclic
A61K31/02:	. Halogenated hydrocarbons
A61K31/025:	. . carbocyclic
A61K31/03:	. . . aromatic
A61K31/035:	. . having aliphatic unsaturation
A61K31/04:	. Nitro compounds
A61K31/045:	. Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A61K31/047:	. . having two or more hydroxy groups, e.g. sorbitol
A61K31/05:	. . Phenols
A61K31/055:	. . . the aromatic ring being substituted by halogen
A61K31/06:	. . . the aromatic ring being substituted by nitro groups
A61K31/065:	. . Diphenyl-substituted acyclic alcohols
A61K31/07:	. . Retinol compounds, e.g. vitamin A
A61K31/075:	. Ethers or acetals
A61K31/08:	. . acyclic, e.g. paraformaldehyde
A61K31/085:	. . having an ether linkage to aromatic ring nuclear carbon
A61K31/09:	. . . having two or more such linkages
A61K31/095:	. Sulfur, selenium or tellurium compounds, e.g. thiols
A61K31/10:	. . Sulfides; Sulfoxides; Sulfones
A61K31/105:	. . Persulfides
A61K31/11:	. Aldehydes
A61K31/115:	. . Formaldehyde
A61K31/12:	. Ketones
A61K31/121:	. . acyclic
A61K31/122:	. . having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K31/125:	. . . Camphor; Nuclear substituted derivatives thereof
A61K31/13:	. Amines, e.g. amantadine
A61K31/131:	. . acyclic
A61K31/132:	. . having two or more amino groups, e.g. spermidine, putrescine
A61K31/133:	. . having hydroxy groups, e.g. sphingosine
A61K31/135:	. . having aromatic rings, e.g. methadone
A61K31/136:	. . . having the amino group directly attached to the aromatic ring, e.g. benzeneamine
A61K31/137:	. . . Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
A61K31/138:	. . . Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K31/14:	. . Quaternary ammonium compounds, e.g. edrophonium, choline
A61K31/145:	. . having sulfur atoms, e.g. thiurams (N—C(S)—S—C(S)—N or N—C(S)—S—S—C(S)—N); Sulfinylamines (—N=SO); Sulfonylamines (—N=SO2)
A61K31/15:	. . Oximes (C=N—O—); Hydrazines (N—N); Hydrazones (N—N=)
A61K31/155:	. . Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)
A61K31/16:	. Amides, e.g. hydroxamic acids
A61K31/164:	. . of a carboxylic acid with an aminoalcohol, e.g. ceramides
A61K31/165:	. . having aromatic rings, e.g. colchicine, atenolol, progabide
A61K31/166:	. . . having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K31/167:	. . . having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
A61K31/17:	. . having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine
A61K31/175:	. . . having the group , N—C(O)—N=N— or , e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
A61K31/18:	. . Sulfonamides
A61K31/185:	. Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A61K31/19:	. . Carboxylic acids, e.g. valproic acid
A61K31/191:	. . . Acyclic acids having two or more hydroxy groups, e.g. gluconic acid
A61K31/192:	. . . having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
A61K31/194:	. . . having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
A61K31/195:	. . . having an amino group
A61K31/196:	. . . . the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
A61K31/197:	. . . . the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid (GABA), beta-alanine, epsilon-aminocaproic acid, pantothenic acid
A61K31/198:	. . . . . Alpha-amino acids, e.g. alanine, edetic acid (EDTA)
A61K31/20:	. . . having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A61K31/201:	. . . . having one or two double bonds, e.g. oleic or linoleic acid
A61K31/202:	. . . . having three or more double bonds, e.g. linolenic acid
A61K31/203:	. . . . Retinoic acids
A61K31/205:	. . Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
A61K31/21:	. Esters, e.g. nitroglycerine, selenocyanates
A61K31/215:	. . of carboxylic acids
A61K31/216:	. . . of acids having aromatic rings, e.g. benactizyne, clofibrate
A61K31/22:	. . . of acyclic acids, e.g. pravastatin
A61K31/221:	. . . . with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
A61K31/222:	. . . . with compounds having aromatic groups, e.g. dipivefrine, ibopamine
A61K31/223:	. . . . of alpha-amino acids
A61K31/225:	. . . . Polycarboxylic acids
A61K31/23:	. . . . of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A61K31/231:	. . . . . having one or two double bonds
A61K31/232:	. . . . . having three or more double bonds, e.g. etretinate
A61K31/235:	. . . having an aromatic ring attached to a carboxyl group
A61K31/24:	. . . . having an amino or nitro group
A61K31/245:	. . . . . Amino benzoic acid types, e.g. procaine, novocaine
A61K31/25:	. . . with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
A61K31/255:	. . of sulfoxy acids or sulfur analogues thereof
A61K31/26:	. . Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
A61K31/265:	. . of carbonic, thiocarbonic or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
A61K31/27:	. . of carbamic or thiocarbamic acids, e.g. meprobamate, carbachol, neostigmine
A61K31/275:	. Nitriles; Isonitriles
A61K31/277:	. . having a ring, e.g. verapamil
A61K31/28:	. Compounds containing heavy metals
A61K31/282:	. . Platinum compounds
A61K31/285:	. . Arsenic compounds
A61K31/29:	. . Antimony or bismuth compounds
A61K31/295:	. . Iron group metal compounds
A61K31/30:	. . Copper compounds
A61K31/305:	. . Mercury compounds
A61K31/31:	. . . containing nitrogen
A61K31/315:	. . Zinc compounds
A61K31/32:	. . Tin compounds
A61K31/325:	. Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
A61K31/327:	. Peroxy compounds, e.g. hydroperoxides, peroxides, peroxy acids
A61K31/33:	. Heterocyclic compounds
A61K31/335:	. . having oxygen as the only ring hetero atom, e.g. fungichromin
A61K31/336:	. . . having three-membered rings, e.g. oxirane, fumagillin
A61K31/337:	. . . having four-membered rings, e.g. taxol
A61K31/34:	. . . having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
A61K31/341:	. . . . not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
A61K31/343:	. . . . condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
A61K31/345:	. . . . Nitrofurans
A61K31/35:	. . . having six-membered rings with one oxygen as the only ring hetero atom
A61K31/351:	. . . . not condensed with another ring
A61K31/352:	. . . . condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K31/353:	. . . . . 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K31/355:	. . . . . . Tocopherols, e.g. vitamin E
A61K31/357:	. . . having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
A61K31/36:	. . . . Compounds containing methylenedioxyphenyl groups, e.g. sesamin
A61K31/365:	. . . Lactones
A61K31/366:	. . . . having six-membered rings, e.g. delta-lactones
A61K31/37:	. . . . . Coumarins, e.g. psoralen
A61K31/375:	. . . . Ascorbic acid, i.e. vitamin C; Salts thereof
A61K31/38:	. . having sulfur as a ring hetero atom
A61K31/381:	. . . having five-membered rings
A61K31/382:	. . . having six-membered rings, e.g. thioxanthenes
A61K31/385:	. . . having two or more sulfur atoms in the same ring
A61K31/39:	. . . having oxygen atoms in the same ring
A61K31/395:	. . having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
A61K31/396:	. . . having three-membered rings, e.g. aziridine
A61K31/397:	. . . having four-membered rings, e.g. azetidine
A61K31/40:	. . . having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K31/401:	. . . . Proline; Derivatives thereof, e.g. captopril
A61K31/4015:	. . . . having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
A61K31/402:	. . . . 1-aryl-substituted, e.g. piretanide
A61K31/4025:	. . . . not condensed and containing further heterocyclic rings, e.g. cromakalim
A61K31/403:	. . . . condensed with carbocyclic rings, e.g. carbazole
A61K31/4035:	. . . . . Isoindoles, e.g. phthalimide
A61K31/404:	. . . . . Indoles, e.g. pindolol
A61K31/4045:	. . . . . . Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
A61K31/405:	. . . . . . Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
A61K31/407:	. . . . condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
A61K31/409:	. . . . having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
A61K31/41:	. . . having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A61K31/415:	. . . . 1,2-Diazoles
A61K31/4152:	. . . . . having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
A61K31/4155:	. . . . . not condensed and containing further heterocyclic rings
A61K31/416:	. . . . . condensed with carbocyclic ring systems, e.g. indazole
A61K31/4162:	. . . . . condensed with heterocyclic ring systems
A61K31/4164:	. . . . 1,3-Diazoles
A61K31/4166:	. . . . . having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
A61K31/4168:	. . . . . having a nitrogen atom attached in position 2, e.g. clonidine
A61K31/417:	. . . . . Imidazole-alkylamines, e.g. histamine, phentolamine
A61K31/4172:	. . . . . Imidazole-alkanecarboxylic acids, e.g. histidine
A61K31/4174:	. . . . . Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
A61K31/4178:	. . . . . not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
A61K31/4184:	. . . . . condensed with carbocyclic rings, e.g. benzimidazoles
A61K31/4188:	. . . . . condensed with heterocyclic ring systems, e.g. biotin, sorbinil
A61K31/4192:	. . . . 1,2,3-Triazoles
A61K31/4196:	. . . . 1,2,4-Triazoles
A61K31/42:	. . . . Oxazoles
A61K31/421:	. . . . . 1,3-Oxazoles, e.g. pemoline, trimethadione
A61K31/422:	. . . . . not condensed and containing further heterocyclic rings
A61K31/423:	. . . . . condensed with carbocyclic rings
A61K31/424:	. . . . . condensed with heterocyclic ring systems, e.g. clavulanic acid
A61K31/4245:	. . . . Oxadiazoles
A61K31/425:	. . . . Thiazoles
A61K31/426:	. . . . . 1,3-Thiazoles
A61K31/427:	. . . . . not condensed and containing further heterocyclic rings
A61K31/428:	. . . . . condensed with carbocyclic rings
A61K31/429:	. . . . . condensed with heterocyclic ring systems
A61K31/43:	. . . . . . Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula , e.g. penicillins, penems
A61K31/431:	containing further heterocyclic ring systems, e.g. ticarcillin, azlocillin, oxacillin
A61K31/433:	. . . . Thiadiazoles
A61K31/435:	. . . having six-membered rings with one nitrogen as the only ring hetero atom
A61K31/4353:	. . . . ortho- or peri-condensed with heterocyclic ring systems
A61K31/4355:	. . . . . the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
A61K31/436:	. . . . . the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
A61K31/4365:	. . . . . the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
A61K31/437:	. . . . . the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
A61K31/4375:	. . . . . the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine
A61K31/438:	. . . . the ring being spiro-condensed with carbocyclic or heterocyclic ring systems
A61K31/439:	. . . . the ring forming part of a bridged ring system, e.g. quinuclidine
A61K31/44:	. . . . Non-condensed pyridines; Hydrogenated derivatives thereof
A61K31/4402:	. . . . . only substituted in position 2, e.g. pheniramine, bisacodyl
A61K31/4406:	. . . . . only substituted in position 3, e.g. zimeldine
A61K31/4409:	. . . . . only substituted in position 4, e.g. isoniazid, iproniazid
A61K31/4412:	. . . . . having oxo groups directly attached to the heterocyclic ring
A61K31/4415:	. . . . . Pyridoxine, i.e.vitamin B6
A61K31/4418:	. . . . . having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine
A61K31/4422:	. . . . . 1,4-Dihydropyridines, e.g. nifedipine, nicardipine
A61K31/4425:	. . . . . Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
A61K31/4427:	. . . . . containing further heterocyclic ring systems
A61K31/443:	. . . . . . containing a five-membered ring with oxygen as a ring hetero atom
A61K31/4433:	. . . . . . containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4436:	. . . . . . containing a heterocyclic ring having sulfur as a ring hetero atom
A61K31/4439:	. . . . . . containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61K31/444:	. . . . . . containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone
A61K31/445:	. . . . . Non-condensed piperidines, e.g. piperocaine
A61K31/4453:	. . . . . . only substituted in position 1, e.g. propipocaine, diperodon
A61K31/4458:	. . . . . . only substituted in position 2, e.g. methylphenidate
A61K31/4462:	. . . . . . only substituted in position 3
A61K31/4465:	. . . . . . only substituted in position 4
A61K31/4468:	. . . . . . having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl
A61K31/45:	. . . . . . having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
A61K31/451:	. . . . . . having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
A61K31/4515:	. . . . . . having a butyrophenone group in position 1, e.g. haloperidol
A61K31/452:	. . . . . . Piperidinium derivatives
A61K31/4523:	. . . . . . containing further heterocyclic ring systems
A61K31/4525:	containing a five-membered ring with oxygen as a ring hetero atom
A61K31/453:	containing a six-membered ring with oxygen as a ring hetero atom
A61K31/4535:	containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
A61K31/454:	containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
A61K31/4545:	containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
A61K31/455:	. . . . . Nicotinic acid, i.e. niacin; Derivatives thereof, e.g. esters, amides
A61K31/46:	. . . . 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
A61K31/465:	. . . . Nicotine; Derivatives thereof
A61K31/47:	. . . . Quinolines; Isoquinolines
A61K31/4704:	. . . . . 2-Quinolinones, e.g. carbostyril
A61K31/4706:	. . . . . 4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
A61K31/4709:	. . . . . Non-condensed quinolines containing further heterocyclic rings
A61K31/472:	. . . . . Non-condensed isoquinolines, e.g. papaverine
A61K31/4725:	. . . . . . containing further heterocyclic rings
A61K31/473:	. . . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
A61K31/4738:	. . . . . ortho- or peri-condensed with heterocyclic ring systems
A61K31/4741:	. . . . . . condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
A61K31/4743:	. . . . . . condensed with ring systems having sulfur as a ring hetero atom
A61K31/4745:	. . . . . . condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
A61K31/4747:	. . . . . spiro-condensed
A61K31/4748:	. . . . . forming part of bridged ring systems
A61K31/475:	. . . . . having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
A61K31/48:	. . . . . Ergoline derivatives, e.g. lysergic acid, ergotamine
A61K31/485:	. . . . . Morphinan derivatives, e.g. morphine, codeine
A61K31/49:	. . . . . Cinchonan derivatives, e.g. quinine
A61K31/495:	. . . having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
A61K31/496:	. . . . Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
A61K31/4965:	. . . . Non-condensed pyrazines
A61K31/497:	. . . . . containing further heterocyclic rings
A61K31/498:	. . . . Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
A61K31/4985:	. . . . Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
A61K31/499:	. . . . Spiro-condensed pyrazines or piperazines
A61K31/4995:	. . . . Pyrazines or piperazines forming part of bridged ring systems
A61K31/50:	. . . . Pyridazines; Hydrogenated pyridazines
A61K31/501:	. . . . . not condensed and containing further heterocyclic rings
A61K31/502:	. . . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
A61K31/5025:	. . . . . ortho- or peri-condensed with heterocyclic ring systems
A61K31/503:	. . . . . spiro-condensed
A61K31/504:	. . . . . forming part of bridged ring systems
A61K31/505:	. . . . Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
A61K31/506:	. . . . . not condensed and containing further heterocyclic rings
A61K31/51:	. . . . . . Thiamines, e.g. vitamin B1
A61K31/513:	. . . . . having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
A61K31/515:	. . . . . . Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
A61K31/517:	. . . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
A61K31/519:	. . . . . ortho- or peri-condensed with heterocyclic rings
A61K31/52:	. . . . . . Purines, e.g. adenine
A61K31/522:	having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A61K31/525:	. . . . . . Isoalloxazines, e.g. riboflavins, vitamin B2
A61K31/527:	. . . . . spiro-condensed
A61K31/529:	. . . . . forming part of bridged ring systems
A61K31/53:	. . . having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
A61K31/535:	. . . having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
A61K31/5355:	. . . . Non-condensed oxazines containing further heterocyclic rings
A61K31/536:	. . . . ortho- or peri-condensed with carbocyclic ring systems
A61K31/5365:	. . . . ortho- or peri-condensed with heterocyclic ring systems
A61K31/537:	. . . . spiro-condensed or forming part of bridged ring systems
A61K31/5375:	. . . . 1,4-Oxazines, e.g. morpholine
A61K31/5377:	. . . . . not condensed and containing further heterocyclic rings, e.g. timolol
A61K31/538:	. . . . . ortho- or peri-condensed with carbocyclic ring systems
A61K31/5383:	. . . . . ortho- or peri-condensed with heterocyclic ring systems
A61K31/5386:	. . . . . spiro-condensed or forming part of bridged ring systems
A61K31/539:	. . . . having two or more oxygen atoms in the same ring, e.g dioxazines
A61K31/5395:	. . . . having two or more nitrogen atoms in the same ring, e.g. oxadiazines
A61K31/54:	. . . having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame
A61K31/541:	. . . . Non-condensed thiazines containing further heterocyclic rings
A61K31/5415:	. . . . ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
A61K31/542:	. . . . ortho- or peri-condensed with heterocyclic ring systems
A61K31/545:	. . . . . Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine
A61K31/546:	. . . . . . containing further heterocyclic rings, e.g. cephalothin
A61K31/547:	. . . . spiro-condensed or forming part of bridged ring systems
A61K31/548:	. . . . having two or more sulfur atoms in the same ring
A61K31/549:	. . . . having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
A61K31/55:	. . . having seven-membered rings, e.g. azelastine, pentylenetetrazole
A61K31/551:	. . . . having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
A61K31/5513:	. . . . . 1,4-Benzodiazepines, e.g. diazepam
A61K31/5517:	. . . . . . condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
A61K31/553:	. . . . having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
A61K31/554:	. . . . having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
A61K31/555:	. . containing heavy metals, e.g. hemin, hematin, melarsoprol
A61K31/557:	. Eicosanoids, e.g. leukotrienes
A61K31/5575:	. . having a cyclopentane ring, e.g. prostaglandin E2, prostaglandin F2-alpha
A61K31/5578:	. . having a pentalene ring system, e.g. carbacyclin, iloprost
A61K31/558:	. . having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
A61K31/5585:	. . . having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
A61K31/559:	. . having heterocyclic rings containing hetero atoms other than oxygen
A61K31/56:	. Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
A61K31/565:	. . not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol
A61K31/566:	. . . having an oxo group in position 17, e.g. oestrone
A61K31/567:	. . . substituted in position 17 alpha, e.g. mestranol, norethandrolone
A61K31/568:	. . . substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone
A61K31/5685:	. . . . having an oxo group in position 17, e.g. androsterone
A61K31/569:	. . . . substituted in position 17 alpha, e.g. ethisterone
A61K31/57:	. . substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
A61K31/573:	. . . substituted in position 21, e.g. cortisone, dexamethasone, prednisone
A61K31/575:	. . substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
A61K31/58:	. . containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin
A61K31/585:	. . . containing lactone rings, e.g. oxandrolone, bufalin
A61K31/59:	. Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems
A61K31/592:	. . 9,10-Secoergostane derivatives, e.g. ergocalciferol, vitamin D2
A61K31/593:	. . 9,10-Secocholestane derivatives, e.g. cholecalciferol, vitamin D3
A61K31/60:	. Salicylic acid; Derivatives thereof
A61K31/603:	. . having further aromatic rings, e.g. diflunisal
A61K31/606:	. . having amino groups
A61K31/609:	. . Amides, e.g. salicylamide
A61K31/612:	. . having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
A61K31/616:	. . . by carboxylic acids, e.g. acetylsalicylic acid
A61K31/618:	. . having the carboxyl group in position 1 esterified, e.g. salsalate
A61K31/621:	. . . having the hydroxy group in position 2 esterified, e.g. benorylate
A61K31/625:	. . having heterocyclic substituents, e.g. 4-salicyloylmorpholine
A61K31/63:	. Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide
A61K31/635:	. . having a heterocyclic ring, e.g. sulfadiazine
A61K31/64:	. Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
A61K31/65:	. Tetracyclines
A61K31/655:	. Azo (—N=N—), diazo (=N2), azoxy (N—O—N or N(=O)—N), azido (—N3) or diazoamino (—N=N—N) compounds
A61K31/66:	. Phosphorus compounds
A61K31/661:	. . Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion
A61K31/6615:	. . . Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
A61K31/662:	. . Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
A61K31/663:	. . . Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
A61K31/664:	. . Amides of phosphorus acids
A61K31/665:	. . having oxygen as a ring hetero atom, e.g. fosfomycin
A61K31/67:	. . having sulfur as a ring hetero atom
A61K31/675:	. . having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
A61K31/683:	. . Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
A61K31/685:	. . . one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
A61K31/688:	. . . both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
A61K31/69:	. Boron compounds
A61K31/695:	. Silicon compounds
A61K31/70:	. Carbohydrates; Sugars; Derivatives thereof
A61K31/7004:	. . Monosaccharides having only carbon, hydrogen and oxygen atoms
A61K31/7008:	. . Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
A61K31/7012:	. . Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
A61K31/7016:	. . Disaccharides, e.g. lactose, lactulose
A61K31/702:	. . Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A61K31/7024:	. . Esters of saccharides
A61K31/7028:	. . Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K31/7032:	. . . attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyl-diacylglycerides, lactobionic acid, gangliosides
A61K31/7034:	. . . attached to a carbocyclic compound, e.g. phloridzin
A61K31/7036:	. . . . having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
A61K31/704:	. . . . attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin, digitoxin
A61K31/7042:	. . Compounds having saccharide radicals and heterocyclic rings
A61K31/7048:	. . . having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61K31/7052:	. . . having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
A61K31/7056:	. . . . containing five-membered rings with nitrogen as a ring hetero atom
A61K31/706:	. . . . containing six-membered rings with nitrogen as a ring hetero atom
A61K31/7064:	. . . . . containing condensed or non-condensed pyrimidines
A61K31/7068:	. . . . . . having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
A61K31/7072:	having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
A61K31/7076:	. . . . . . containing purines, e.g. adenosine, adenylic acid
A61K31/708:	having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
A61K31/7084:	. . Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
A61K31/7088:	. . Compounds having three or more nucleosides or nucleotides
A61K31/7105:	. . . Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
A61K31/711:	. . . Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
A61K31/7115:	. . . Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
A61K31/712:	. . . Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
A61K31/7125:	. . . Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
A61K31/713:	. . . Double-stranded nucleic acids or oligonucleotides
A61K31/7135:	. . Compounds containing heavy metals
A61K31/714:	. . . Cobalamins, e.g. cyanocobalamin, vitamin B12
A61K31/715:	. . Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
A61K31/716:	. . . Glucans
A61K31/717:	. . . . Celluloses
A61K31/718:	. . . . Starch or degraded starch, e.g. amylose, amylopectin
A61K31/719:	. . . . Pullulans
A61K31/721:	. . . . Dextrans
A61K31/722:	. . . . Chitin; Chitosan
A61K31/723:	. . . . Xanthans
A61K31/724:	. . . . Cyclodextrins
A61K31/726:	. . . Glycosaminoglycans, i.e. mucopolysaccharides
A61K31/727:	. . . . Heparin; Heparan
A61K31/728:	. . . . Hyaluronic acid
A61K31/729:	. . . Agar; Agarose; Agaropectin
A61K31/731:	. . . Carrageenans
A61K31/732:	. . . Pectin
A61K31/733:	. . . Fructosans, e.g. inulin
A61K31/734:	. . . Alginic acid
A61K31/736:	. . . Glucomannans or galactomannans, e.g locust bean gum, guar gum
A61K31/737:	. . . Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
A61K31/738:	. . . Cross-linked polysaccharides
A61K31/739:	. . . Lipopolysaccharides
A61K31/74:	. Synthetic polymeric materials
A61K31/745:	. . Polymers of hydrocarbons
A61K31/75:	. . . of ethene
A61K31/755:	. . Polymers containing halogen
A61K31/76:	. . . of vinyl chloride
A61K31/765:	. . Polymers containing oxygen
A61K31/77:	. . . of oxiranes
A61K31/775:	. . . Phenolic resins
A61K31/78:	. . . of acrylic acid or derivatives thereof
A61K31/785:	. . Polymers containing nitrogen
A61K31/787:	. . . containing heterocyclic rings having nitrogen as a ring hetero atom
A61K31/79:	. . . . Polymers of vinyl pyrrolidone
A61K31/795:	. . Polymers containing sulfur
A61K31/80:	. . Polymers containing hetero atoms not provided for in groups
A61K33/00:	Medicinal preparations containing inorganic active ingredients
A61K33/02:	. Ammonia; Compounds thereof
A61K33/04:	. Sulfur, selenium or tellurium; Compounds thereof
A61K33/06:	. Aluminium, calcium or magnesium; Compounds thereof
A61K33/08:	. . Oxides; Hydroxides
A61K33/10:	. . Carbonates; Bicarbonates
A61K33/12:	. . Magnesium silicate
A61K33/14:	. Alkali metal chlorides; Alkaline earth metal chlorides
A61K33/16:	. Fluorine compounds
A61K33/18:	. Iodine; Compounds thereof
A61K33/20:	. Elemental chlorine; Inorganic compounds releasing chlorine
A61K33/22:	. Boron compounds
A61K33/24:	. Heavy metals; Compounds thereof
A61K33/26:	. . Iron; Compounds thereof
A61K33/28:	. . Mercury; Compounds thereof
A61K33/30:	. . Zinc; Compounds thereof
A61K33/32:	. . Manganese; Compounds thereof
A61K33/34:	. . Copper; Compounds thereof
A61K33/36:	. . Arsenic; Compounds thereof
A61K33/38:	. . Silver; Compounds thereof
A61K33/40:	. Peroxides
A61K33/42:	. Phosphorus; Compounds thereof
A61K33/44:	. Elemental carbon, e.g. charcoal, carbon black
A61K35/00:	Medicinal preparations containing materials or reaction products thereof with undetermined constitution
A61K35/02:	. from inanimate materials
A61K35/04:	. . Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
A61K35/06:	. . . Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
A61K35/08:	. . Mineral waters; Seawater
A61K35/10:	. . Peat; Amber; Turf; Humus
A61K35/12:	. Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
A61K35/13:	. . Tumour cells, irrespective of tissue of origin
A61K35/14:	. . Blood; Artificial blood
A61K35/15:	. . . Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
A61K35/16:	. . . Blood plasma; Blood serum
A61K35/17:	. . . Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
A61K35/18:	. . . Erythrocytes
A61K35/19:	. . . Platelets; Megacaryocytes
A61K35/20:	. . Milk; Whey; Colostrum
A61K35/22:	. . Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
A61K35/23:	. . . Kidney
A61K35/24:	. . Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
A61K35/26:	. . Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
A61K35/28:	. . Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
A61K35/30:	. . Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
A61K35/32:	. . Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
A61K35/33:	. . Fibroblasts
A61K35/34:	. . Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
A61K35/35:	. . Fat tissue; Adipocytes; Stromal cells; Connective tissues
A61K35/36:	. . Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
A61K35/37:	. . Digestive system
A61K35/38:	. . . Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
A61K35/39:	. . . Pancreas; Islets of Langerhans
A61K35/407:	. . . Liver; Hepatocytes
A61K35/413:	. . . Gall bladder; Bile
A61K35/42:	. . Respiratory system, e.g. lungs, bronchi or lung cells
A61K35/44:	. . Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
A61K35/48:	. . Reproductive organs
A61K35/50:	. . . Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
A61K35/51:	. . . Umbilical cord; Umbilical cord blood; Umbilical stem cells
A61K35/52:	. . . Sperm; Prostate; Seminal fluid; Leydig cells of testes
A61K35/54:	. . . Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
A61K35/545:	. . . . Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
A61K35/55:	. . Glands not provided for in groups , e.g. thyroids, parathyroids or pineal glands
A61K35/56:	. Materials from animals other than mammals
A61K35/57:	. . Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K35/58:	. . Reptiles
A61K35/583:	. . . Snakes; Lizards, e.g. chameleons
A61K35/586:	. . . Turtles; Tortoises, e.g. terrapins
A61K35/60:	. . Fish, e.g. seahorses; Fish eggs
A61K35/612:	. . Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
A61K35/614:	. . Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish
A61K35/616:	. . Echinodermata, e.g. starfish, sea cucumbers or sea urchins
A61K35/618:	. . Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
A61K35/62:	. . Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
A61K35/63:	. . Arthropods
A61K35/64:	. . . Insects, e.g. bees, wasps or fleas
A61K35/644:	. . . . Beeswax; Propolis; Royal jelly; Honey
A61K35/646:	. . . Arachnids, e.g. spiders, scorpions, ticks or mites
A61K35/648:	. . . Myriapods, e.g. centipedes or millipedes
A61K35/65:	. . Amphibians, e.g. toads, frogs, salamanders or newts
A61K35/655:	. . Aquatic animals other than those covered by groups
A61K35/66:	. Microorganisms or materials therefrom
A61K35/68:	. . Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
A61K35/74:	. . Bacteria
A61K35/741:	. . . Probiotics
A61K35/742:	. . . . Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
A61K35/744:	. . . . Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
A61K35/745:	. . . . . Bifidobacteria
A61K35/747:	. . . . . Lactobacilli, e.g. L. acidophilus or L. brevis
A61K35/748:	. . . Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
A61K35/76:	. . Viruses; Subviral particles; Bacteriophages
A61K35/761:	. . . Adenovirus
A61K35/763:	. . . Herpes virus
A61K35/765:	. . . Reovirus; Rotavirus
A61K35/766:	. . . Rhabdovirus, e.g. vesicular stomatitis virus
A61K35/768:	. . . Oncolytic viruses not provided for in groups
A61K36/00:	Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K36/02:	. Algae
A61K36/03:	. . Phaeophycota or phaeophyta (brown algae), e.g. Fucus
A61K36/04:	. . Rhodophycota or rhodophyta (red algae), e.g. Porphyra
A61K36/05:	. . Chlorophycota or chlorophyta (green algae), e.g. Chlorella
A61K36/06:	. Fungi, e.g. yeasts
A61K36/062:	. . Ascomycota
A61K36/064:	. . . Saccharomycetales, e.g. baker's yeast
A61K36/066:	. . . Clavicipitaceae
A61K36/068:	. . . . Cordyceps
A61K36/07:	. . Basidiomycota, e.g. Cryptococcus
A61K36/074:	. . . Ganoderma
A61K36/076:	. . . Poria
A61K36/09:	. Lichens
A61K36/10:	. Bryophyta (mosses)
A61K36/11:	. Pteridophyta or Filicophyta (ferns)
A61K36/12:	. . Filicopsida or Pteridopsida
A61K36/126:	. . . Drynaria
A61K36/13:	. Coniferophyta (gymnosperms)
A61K36/14:	. . Cupressaceae (Cypress family), e.g. juniper or cypress
A61K36/15:	. . Pinaceae (Pine family), e.g. pine or cedar
A61K36/16:	. Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
A61K36/17:	. Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
A61K36/18:	. Magnoliophyta (angiosperms)
A61K36/185:	. . Magnoliopsida (dicotyledons)
A61K36/19:	. . . Acanthaceae (Acanthus family)
A61K36/195:	. . . . Strobilanthes
A61K36/20:	. . . Aceraceae (Maple family)
A61K36/21:	. . . Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
A61K36/22:	. . . Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
A61K36/23:	. . . Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
A61K36/232:	. . . . Angelica
A61K36/233:	. . . . Bupleurum
A61K36/234:	. . . . Cnidium (snowparsley)
A61K36/235:	. . . . Foeniculum (fennel)
A61K36/236:	. . . . Ligusticum (licorice-root)
A61K36/237:	. . . . Notopterygium
A61K36/238:	. . . . Saposhnikovia
A61K36/24:	. . . Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
A61K36/25:	. . . Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
A61K36/254:	. . . . Acanthopanax or Eleutherococcus
A61K36/258:	. . . . Panax (ginseng)
A61K36/26:	. . . Aristolochiaceae (Birthwort family), e.g. heartleaf
A61K36/264:	. . . . Aristolochia (Dutchman's pipe)
A61K36/268:	. . . . Asarum (wild ginger)
A61K36/27:	. . . Asclepiadaceae (Milkweed family), e.g. hoya
A61K36/28:	. . . Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
A61K36/282:	. . . . Artemisia, e.g. wormwood or sagebrush
A61K36/284:	. . . . Atractylodes
A61K36/285:	. . . . Aucklandia
A61K36/286:	. . . . Carthamus (distaff thistle)
A61K36/287:	. . . . Chrysanthemum, e.g. daisy
A61K36/288:	. . . . Taraxacum (dandelion)
A61K36/289:	. . . . Vladimiria
A61K36/29:	. . . Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
A61K36/296:	. . . . Epimedium
A61K36/30:	. . . Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
A61K36/31:	. . . Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
A61K36/315:	. . . . Isatis, e.g. Dyer's woad
A61K36/32:	. . . Burseraceae (Frankincense family)
A61K36/324:	. . . . Boswellia, e.g. frankincense
A61K36/328:	. . . . Commiphora, e.g. mecca myrrh or balm of Gilead
A61K36/33:	. . . Cactaceae (Cactus family), e.g. pricklypear or Cereus
A61K36/34:	. . . Campanulaceae (Bellflower family)
A61K36/342:	. . . . Adenophora
A61K36/344:	. . . . Codonopsis
A61K36/346:	. . . . Platycodon
A61K36/35:	. . . Caprifoliaceae (Honeysuckle family)
A61K36/355:	. . . . Lonicera (honeysuckle)
A61K36/36:	. . . Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
A61K36/37:	. . . Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
A61K36/38:	. . . Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
A61K36/39:	. . . Convolvulaceae (Morning-glory family), e.g. bindweed
A61K36/40:	. . . Cornaceae (Dogwood family)
A61K36/41:	. . . Crassulaceae (Stonecrop family)
A61K36/42:	. . . Cucurbitaceae (Cucumber family)
A61K36/424:	. . . . Gynostemma
A61K36/428:	. . . . Trichosanthes
A61K36/43:	. . . Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
A61K36/44:	. . . Ebenaceae (Ebony family), e.g. persimmon
A61K36/45:	. . . Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
A61K36/46:	. . . Eucommiaceae (Eucommia family), e.g. hardy rubber tree
A61K36/47:	. . . Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
A61K36/48:	. . . Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
A61K36/481:	. . . . Astragalus (milkvetch)
A61K36/482:	. . . . Cassia, e.g. golden shower tree
A61K36/483:	. . . . Gleditsia (locust)
A61K36/484:	. . . . Glycyrrhiza (licorice)
A61K36/485:	. . . . Gueldenstaedtia
A61K36/486:	. . . . Millettia
A61K36/487:	. . . . Psoralea
A61K36/488:	. . . . Pueraria (kudzu)
A61K36/489:	. . . . Sophora, e.g. necklacepod or mamani
A61K36/49:	. . . Fagaceae (Beech family), e.g. oak or chestnut
A61K36/50:	. . . Fumariaceae (Fumitory family), e.g. bleeding heart
A61K36/505:	. . . . Corydalis
A61K36/51:	. . . Gentianaceae (Gentian family)
A61K36/515:	. . . . Gentiana
A61K36/52:	. . . Juglandaceae (Walnut family)
A61K36/53:	. . . Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
A61K36/532:	. . . . Agastache, e.g. giant hyssop
A61K36/533:	. . . . Leonurus (motherwort)
A61K36/534:	. . . . Mentha (mint)
A61K36/535:	. . . . Perilla (beefsteak plant)
A61K36/536:	. . . . Prunella or Brunella (selfheal)
A61K36/537:	. . . . Salvia (sage)
A61K36/538:	. . . . Schizonepeta
A61K36/539:	. . . . Scutellaria (skullcap)
A61K36/54:	. . . Lauraceae (Laurel family), e.g. cinnamon or sassafras
A61K36/55:	. . . Linaceae (Flax family), e.g. Linum
A61K36/56:	. . . Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
A61K36/57:	. . . Magnoliaceae (Magnolia family)
A61K36/575:	. . . . Magnolia
A61K36/58:	. . . Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
A61K36/59:	. . . Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
A61K36/60:	. . . Moraceae (Mulberry family), e.g. breadfruit or fig
A61K36/605:	. . . . Morus (mulberry)
A61K36/61:	. . . Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
A61K36/62:	. . . Nymphaeaceae (Water-lily family)
A61K36/63:	. . . Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
A61K36/634:	. . . . Forsythia
A61K36/638:	. . . . Ligustrum, e.g. Chinese privet
A61K36/64:	. . . Orobanchaceae (Broom-rape family)
A61K36/65:	. . . Paeoniaceae (Peony family), e.g. Chinese peony
A61K36/66:	. . . Papaveraceae (Poppy family), e.g. bloodroot
A61K36/67:	. . . Piperaceae (Pepper family), e.g. Jamaican pepper or kava
A61K36/68:	. . . Plantaginaceae (Plantain Family)
A61K36/69:	. . . Polygalaceae (Milkwort family)
A61K36/70:	. . . Polygonaceae (Buckwheat family), e.g. spineflower or dock
A61K36/704:	. . . . Polygonum, e.g. knotweed
A61K36/708:	. . . . Rheum (rhubarb)
A61K36/71:	. . . Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
A61K36/714:	. . . . Aconitum (monkshood)
A61K36/716:	. . . . Clematis (leather flower)
A61K36/718:	. . . . Coptis (goldthread)
A61K36/72:	. . . Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
A61K36/725:	. . . . Ziziphus, e.g. jujube
A61K36/73:	. . . Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
A61K36/732:	. . . . Chaenomeles, e.g. flowering quince
A61K36/734:	. . . . Crataegus (hawthorn)
A61K36/736:	. . . . Prunus, e.g. plum, cherry, peach, apricot or almond
A61K36/738:	. . . . Rosa (rose)
A61K36/739:	. . . . Sanguisorba (burnet)
A61K36/74:	. . . Rubiaceae (Madder family)
A61K36/744:	. . . . Gardenia
A61K36/746:	. . . . Morinda
A61K36/748:	. . . . Oldenlandia or Hedyotis
A61K36/75:	. . . Rutaceae (Rue family)
A61K36/752:	. . . . Citrus, e.g. lime, orange or lemon
A61K36/754:	. . . . Evodia
A61K36/756:	. . . . Phellodendron, e.g. corktree
A61K36/758:	. . . . Zanthoxylum, e.g. pricklyash
A61K36/76:	. . . Salicaceae (Willow family), e.g. poplar
A61K36/77:	. . . Sapindaceae (Soapberry family), e.g. lychee or soapberry
A61K36/78:	. . . Saururaceae (Lizard's-tail family)
A61K36/79:	. . . Schisandraceae (Schisandra family)
A61K36/80:	. . . Scrophulariaceae (Figwort family)
A61K36/804:	. . . . Rehmannia
A61K36/808:	. . . . Scrophularia (figwort)
A61K36/81:	. . . Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
A61K36/815:	. . . . Lycium (desert-thorn)
A61K36/82:	. . . Theaceae (Tea family), e.g. camellia
A61K36/83:	. . . Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
A61K36/835:	. . . . Aquilaria
A61K36/84:	. . . Valerianaceae (Valerian family), e.g. valerian
A61K36/85:	. . . Verbenaceae (Verbena family)
A61K36/855:	. . . . Clerodendrum, e.g. glorybower
A61K36/86:	. . . Violaceae (Violet family)
A61K36/87:	. . . Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
A61K36/88:	. . Liliopsida (monocotyledons)
A61K36/882:	. . . Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
A61K36/884:	. . . Alismataceae (Water-plantain family)
A61K36/886:	. . . Aloeaceae (Aloe family), e.g. aloe vera
A61K36/888:	. . . Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
A61K36/8884:	. . . . Arisaema, e.g. Jack in the pulpit
A61K36/8888:	. . . . Pinellia
A61K36/889:	. . . Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
A61K36/8895:	. . . . Calamus, e.g. rattan
A61K36/89:	. . . Cyperaceae (Sedge family)
A61K36/8905:	. . . . Cyperus (flatsedge)
A61K36/894:	. . . Dioscoreaceae (Yam family)
A61K36/8945:	. . . . Dioscorea, e.g. yam, Chinese yam or water yam
A61K36/896:	. . . Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
A61K36/8962:	. . . . Allium, e.g. garden onion, leek, garlic or chives
A61K36/8964:	. . . . Anemarrhena
A61K36/8965:	. . . . Asparagus, e.g. garden asparagus or asparagus fern
A61K36/8966:	. . . . Fritillaria, e.g. checker lily or mission bells
A61K36/8967:	. . . . Lilium, e.g. tiger lily or Easter lily
A61K36/8968:	. . . . Ophiopogon (Lilyturf)
A61K36/8969:	. . . . Polygonatum (Solomon's seal)
A61K36/898:	. . . Orchidaceae (Orchid family)
A61K36/8984:	. . . . Dendrobium
A61K36/8988:	. . . . Gastrodia
A61K36/899:	. . . Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
A61K36/8994:	. . . . Coix (Job's tears)
A61K36/8998:	. . . . Hordeum (barley)
A61K36/90:	. . . Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
A61K36/902:	. . . Sparganiaceae (Bur-reed family)
A61K36/904:	. . . Stemonaceae (Stemona family), e.g. croomia
A61K36/906:	. . . Zingiberaceae (Ginger family)
A61K36/9062:	. . . . Alpinia, e.g. red ginger or galangal
A61K36/9064:	. . . . Amomum, e.g. round cardamom
A61K36/9066:	. . . . Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
A61K36/9068:	. . . . Zingiber, e.g. garden ginger
A61K38/00:	Medicinal preparations containing peptides
A61K38/01:	. Hydrolysed proteins; Derivatives thereof
A61K38/02:	. Peptides of undefined number of amino acids; Derivatives thereof
A61K38/03:	. Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
A61K38/04:	. Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
A61K38/05:	. . Dipeptides
A61K38/06:	. . Tripeptides
A61K38/07:	. . Tetrapeptides
A61K38/08:	. . Peptides having 5 to 11 amino acids
A61K38/09:	. . . Luteinising hormone-releasing hormone (LHRH); Related peptides
A61K38/10:	. . Peptides having 12 to 20 amino acids
A61K38/11:	. . . Oxytocins; Vasopressins; Related peptides
A61K38/12:	. . Cyclic peptides
A61K38/13:	. . . Cyclosporins
A61K38/14:	. . Peptides containing saccharide radicals; Derivatives thereof
A61K38/15:	. . Depsipeptides; Derivatives thereof
A61K38/16:	. Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K38/17:	. . from animals; from humans
A61K38/18:	. . . Growth factors; Growth regulators
A61K38/19:	. . . Cytokines; Lymphokines; Interferons
A61K38/20:	. . . . Interleukins
A61K38/21:	. . . . Interferons
A61K38/22:	. . . Hormones
A61K38/23:	. . . . Calcitonins
A61K38/24:	. . . . Follicle-stimulating hormone (FSH); Chorionic gonadotropins, e.g. HCG; Luteinising hormone (LH); Thyroid-stimulating hormone (TSH)
A61K38/25:	. . . . Growth hormone-releasing factor (GH-RF) (Somatoliberin)
A61K38/26:	. . . . Glucagons
A61K38/27:	. . . . Growth hormone (GH) (Somatotropin)
A61K38/28:	. . . . Insulins
A61K38/29:	. . . . Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
A61K38/30:	. . . . Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
A61K38/31:	. . . . Somatostatins
A61K38/32:	. . . . Thymopoietins
A61K38/33:	. . . derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
A61K38/34:	. . . . Melanocyte stimulating hormone (MSH), e.g. alpha- or beta-melanotropin
A61K38/35:	. . . . Corticotropin (ACTH)
A61K38/36:	. . . Blood coagulation or fibrinolysis factors
A61K38/37:	. . . . Factors VIII
A61K38/38:	. . . Albumins
A61K38/39:	. . . Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin (CIG)
A61K38/40:	. . . Transferrins, e.g. lactoferrins, ovotransferrins
A61K38/41:	. . Porphyrin- or corrin-ring-containing peptides
A61K38/42:	. . . Haemoglobins; Myoglobins
A61K38/43:	. . Enzymes; Proenzymes; Derivatives thereof
A61K38/44:	. . . Oxidoreductases (1)
A61K38/45:	. . . Transferases (2)
A61K38/46:	. . . Hydrolases (3)
A61K38/47:	. . . . acting on glycosyl compounds (3.2), e.g. cellulases, lactases
A61K38/48:	. . . . acting on peptide bonds (3.4)
A61K38/49:	. . . . . Urokinase; Tissue plasminogen activator
A61K38/50:	. . . . acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
A61K38/51:	. . . Lyases (4)
A61K38/52:	. . . Isomerases (5)
A61K38/53:	. . . Ligases (6)
A61K38/54:	. . . Mixtures of enzymes or proenzymes covered by more than a single one of groups or
A61K38/55:	. . Protease inhibitors
A61K38/56:	. . . from plants
A61K38/57:	. . . from animals; from humans
A61K38/58:	. . . . from leeches, e.g. hirudin, eglin
A61K39/00:	Medicinal preparations containing antigens or antibodies
A61K39/002:	. Protozoa antigens
A61K39/005:	. . Trypanosoma antigens
A61K39/008:	. . Leishmania antigens
A61K39/012:	. . Coccidia antigens
A61K39/015:	. . Hemosporidia antigens, e.g. Plasmodium antigens
A61K39/018:	. . . Babesia antigens, e.g. Theileria antigens
A61K39/02:	. Bacterial antigens
A61K39/04:	. . Mycobacterium, e.g. Mycobacterium tuberculosis
A61K39/05:	. . Corynebacterium; Propionibacterium
A61K39/07:	. . Bacillus
A61K39/08:	. . Clostridium, e.g. Clostridium tetani
A61K39/085:	. . Staphylococcus
A61K39/09:	. . Streptococcus
A61K39/095:	. . Neisseria
A61K39/10:	. . Brucella; Bordetella, e.g. Bordetella pertussis
A61K39/102:	. . Pasteurella; Haemophilus
A61K39/104:	. . Pseudomonas
A61K39/106:	. . Vibrio; Campylobacter
A61K39/108:	. . Escherichia; Klebsiella
A61K39/112:	. . Salmonella; Shigella
A61K39/114:	. . Fusobacterium
A61K39/116:	. . Polyvalent bacterial antigens
A61K39/118:	. Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
A61K39/12:	. Viral antigens
A61K39/125:	. . Picornaviridae, e.g. calicivirus
A61K39/13:	. . . Poliovirus
A61K39/135:	. . . Foot-and-mouth disease virus
A61K39/145:	. . Orthomyxoviridae, e.g. influenza virus
A61K39/15:	. . Reoviridae, e.g. calf diarrhea virus
A61K39/155:	. . Paramyxoviridae, e.g. parainfluenza virus
A61K39/165:	. . . Mumps or measles virus
A61K39/17:	. . . Newcastle disease virus
A61K39/175:	. . . Canine distemper virus
A61K39/187:	. . Hog cholera virus
A61K39/193:	. . Equine encephalomyelitis virus
A61K39/20:	. . Rubella virus
A61K39/205:	. . Rhabdoviridae, e.g. rabies virus
A61K39/21:	. . Retroviridae, e.g. equine infectious anemia virus
A61K39/215:	. . Coronaviridae, e.g. avian infectious bronchitis virus
A61K39/225:	. . . Porcine transmissible gastroenteritis virus
A61K39/23:	. . Parvoviridae, e.g. feline panleukopenia virus
A61K39/235:	. . Adenoviridae
A61K39/245:	. . Herpetoviridae, e.g. herpes simplex virus
A61K39/25:	. . . Varicella-zoster virus
A61K39/255:	. . . Marek's disease virus
A61K39/265:	. . . Infectious rhinotracheitis virus
A61K39/27:	. . . Equine rhinopneumonitis virus
A61K39/275:	. . Poxviridae, e.g. avipoxvirus
A61K39/285:	. . . Vaccinia virus or variola virus
A61K39/29:	. . Hepatitis virus
A61K39/295:	. . Polyvalent viral antigens; Mixtures of viral and bacterial antigens
A61K39/35:	. Allergens
A61K39/36:	. . from pollen
A61K39/38:	. Antigens from snakes
A61K39/385:	. Haptens or antigens, bound to carriers
A61K39/39:	. characterised by the immunostimulating additives, e.g. chemical adjuvants
A61K39/395:	. Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A61K39/40:	. . bacterial
A61K39/42:	. . viral
A61K39/44:	. . Antibodies bound to carriers
A61K41/00:	Medicinal preparations obtained by treating materials with wave energy or particle radiation
A61K45/00:	Medicinal preparations containing active ingredients not provided for in groups
A61K45/06:	. Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61K45/08:	. Mixtures of an active ingredient and an auxiliary substance neither being chemically characterised, e.g. antihistaminicum and surface active substance
A61K47/00:	Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
A61K47/02:	. Inorganic compounds
A61K47/04:	. . Non-metals; Compounds thereof
A61K47/06:	. Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
A61K47/08:	. . containing oxygen
A61K47/10:	. . . Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
A61K47/12:	. . . Carboxylic acids; Salts or anhydrides thereof
A61K47/14:	. . . Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
A61K47/16:	. . containing nitrogen
A61K47/18:	. . . Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
A61K47/20:	. . containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
A61K47/22:	. . Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
A61K47/24:	. . containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
A61K47/26:	. . Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
A61K47/28:	. . Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
A61K47/30:	. Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
A61K47/32:	. . Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers
A61K47/34:	. . Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
A61K47/36:	. . Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
A61K47/38:	. . . Cellulose; Derivatives thereof
A61K47/40:	. . . Cyclodextrins; Derivatives thereof
A61K47/42:	. . Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
A61K47/44:	. Oils, fats or waxes according to two or more groups of ; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
A61K47/46:	. Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
A61K47/48:	. the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
A61K47/50:	. the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
A61K47/51:	. . the non-active ingredient being a modifying agent
A61K47/52:	. . . the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
A61K47/54:	. . . the modifying agent being an organic compound
A61K47/55:	. . . . the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
A61K47/56:	. . . the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
A61K47/58:	. . . . obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
A61K47/59:	. . . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
A61K47/60:	. . . . . the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
A61K47/61:	. . . . the organic macromolecular compound being a polysaccharide or a derivative thereof
A61K47/62:	. . . the modifying agent being a protein, peptide or polyamino acid
A61K47/64:	. . . . Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
A61K47/65:	. . . . Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
A61K47/66:	. . . . the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
A61K47/68:	. . . the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
A61K47/69:	. . the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
A61K48/00:	Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
A61K49/00:	Preparations for testing in vivo
A61K49/04:	. X-ray contrast preparations
A61K49/06:	. Nuclear magnetic resonance (NMR) contrast preparations; Magnetic resonance imaging (MRI) contrast preparations
A61K49/08:	. . characterised by the carrier
A61K49/10:	. . . Organic compounds
A61K49/12:	. . . . Macromolecular compounds
A61K49/14:	. . . . Peptides, e.g. proteins
A61K49/16:	. . . . . Antibodies; Immunoglobulins; Fragments thereof
A61K49/18:	. . characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
A61K49/20:	. . containing free radicals
A61K49/22:	. Echographic preparations; Ultrasound imaging preparations
A61K50/00:	Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ECG) or for transcutaneous drug administration
A61K51/00:	Preparations containing radioactive substances for use in therapy or testing in vivo
A61K51/02:	. characterised by the carrier
A61K51/04:	. . Organic compounds
A61K51/06:	. . . Macromolecular compounds
A61K51/08:	. . . Peptides, e.g. proteins
A61K51/10:	. . . . Antibodies or immunoglobulins; Fragments thereof
A61K51/12:	. characterised by a special physical form, e.g. emulsion, microcapsules, liposomes
A61K101/00:	Radioactive non-metals
A61K101/02:	. Halogens
A61K103/00:	Radioactive metals
A61K103/10:	. Technetium; Rhenium
A61K103/20:	. Indium
A61K103/30:	. Rare earths
A61K103/32:	. . Yttrium
A61K103/34:	. . Gadolinium
A61K103/36:	. . Ytterbium
A61K103/40:	. Actinides
A61K125/00:	Containing or obtained from roots, bulbs, tubers, corms or rhizomes
A61K127/00:	Containing or obtained from leaves
A61K129/00:	Containing or obtained from bark
A61K131/00:	Containing or obtained from seeds, nuts, fruits or grains
A61K133/00:	Containing or obtained from flowers or blossoms
A61K135/00:	Containing or obtained from stems, stalks, branches, twigs or shoots